| Prevalence, % | 95% confidence intervals | No. studies | No. participants | Heterogeneity | Egger test | P value, difference | |
---|---|---|---|---|---|---|---|---|
I2, % | P value | |||||||
Global | 36.1 | 33.7–38.5 | 329 | 462 104 | 99.5 |  < 0.0001 | 0.0002 | … |
 All participants on ART | 34.5 | 31.8–37.2 | 268 | 420 575 | 99.6 |  < 0.0001 | 0.0001 | … |
Country level of income | ||||||||
 Low | 10.1 | 6.8–14.1 | 30 | 11 329 | 95.9 |  < 0.0001 | 0.095 |  < 0.0001 |
 Lower-middle | 16.0 | 8.6–25.3 | 21 | 9858 | 98.7 |  < 0.0001 | 0.496 |  |
 Upper-middle | 27.6 | 23.8–31.6 | 39 | 8252 | 90.4 |  < 0.0001 | 0.668 |  |
 High | 45.2 | 42.7–47.7 | 216 | 339 022 | 99.5 |  < 0.0001 | 0.527 |  |
UNAIDS region | ||||||||
 West and Central Africa | 4.4 | 2.9–6.3 | 12 | 4868 | 87.0 |  < 0.0001 | 0.263 |  < 0.0001 |
 Eastern and Southern Africa | 10.7 | 7.8–14.0 | 34 | 12 676 | 94.8 |  < 0.0001 | 0.080 |  |
 Latin America and the Caribbean | 28.8 | 25.0–32.8 | 24 | 16 385 | 95.9 |  < 0.0001 | 0.162 |  |
 Asia and Pacific | 32.6 | 26.6–38.9 | 27 | 16 352 | 97.3 |  < 0.0001 | 0.031 |  |
 Middle East and North Africa | 32.9 | 16.1–52.4 | 3 | 320 | 93.0 |  < 0.0001 | 0.711 |  |
 Eastern Europe and Central Asia | 43.1 | 15.8–72.9 | 2 | 264 | 95.9 |  < 0.0001 | NA |  |
 West and Central Europe and North America | 45.4 | 42.7–48.1 | 203 | 293 547 | 99.5 |  < 0.0001 | 0.339 |  |